SNAPSHOT: Biopsy Device Market Size To Exceed $2.3bn by 2021
Executive Summary
Cancer rates are anticipated to rise significantly across the world by 2025, driving a sales growth of biopsy devices from approximately $1.6bn in 2016 to an estimated $2.3bn in 2021. The US currently holds the largest market share but sales in the rest of the world (RoW) is expected to experience the largest amount of growth over the forecast period, according to a report by Meddevicetracker.
You may also be interested in...
Can Organovo Leverage Its Solid Phase II Data In MASH?
Cash-limited Organovo has an FXR agonist showing competitive efficacy and tolerability in MASH, but may need a partner to move forward in that disease as it may be prioritizing its IBD program.
Cullinan Changes Tracks, Moving Lymphoma Bispecific Into Autoimmune
The company will discontinue its trial of the CD19-directed bispecific CLN-978 in NHL and develop it in inflammatory diseases, where it could have an edge over CAR-Ts.
Interview: Theradaptive To Enter Clinical Trial For Spinal Fusion Gel
Theradaptive, which makes a device-biologic combination product to help speed bone healing, recently got authorization to start human trials from the US FDA. Medtech Insight spoke to CEO Luis Alvarez about the company’s past, present and future.